Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
24.19
-0.05 (-0.21%)
At close: Jun 27, 2025, 4:00 PM
24.17
-0.02 (-0.08%)
After-hours: Jun 27, 2025, 7:59 PM EDT
Pfizer Stock Forecast
Stock Price Forecast
According to 13 professional analysts, the 12-month price target for Pfizer stock ranges from a low of $24 to a high of $45. The average analyst price target of $29.92 forecasts a 23.69% increase in the stock price over the next year.
Price Target: $29.92 (+23.69%)
Analyst Consensus: Hold
* Price targets were last updated on Apr 30, 2025.
Analyst Ratings
The average analyst rating for Pfizer stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Hold | 8 | 8 | 8 | 9 | 9 | 9 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 14 | 15 | 15 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $24 → $25 | Hold | Maintains | $24 → $25 | +3.35% | Apr 30, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Initiates $24 | Hold | Initiates | $24 | -0.79% | Apr 22, 2025 |
| UBS | UBS | Hold Maintains $28 → $24 | Hold | Maintains | $28 → $24 | -0.79% | Apr 8, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $32 → $25 | Strong Buy → Hold | Downgrades | $32 → $25 | +3.35% | Apr 8, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Mar 18, 2025 |
Financial Forecast
Revenue This Year
63.05B
from 63.63B
Decreased by -0.91%
Revenue Next Year
62.83B
from 63.05B
Decreased by -0.34%
EPS This Year
3.04
from 1.41
Increased by 115.04%
EPS Next Year
3.12
from 3.04
Increased by 2.89%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 67.2B | 67.4B | 67.6B | ||
| Avg | 63.0B | 62.8B | 61.4B | ||
| Low | 59.4B | 58.0B | 56.1B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 5.5% | 6.9% | 7.5% | ||
| Avg | -0.9% | -0.3% | -2.4% | ||
| Low | -6.7% | -8.0% | -10.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.50 | 3.64 | 3.85 | ||
| Avg | 3.04 | 3.12 | 3.12 | ||
| Low | 2.74 | 2.68 | 2.73 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 147.6% | 20.0% | 23.4% | ||
| Avg | 115.0% | 2.9% | -0.0% | ||
| Low | 94.3% | -11.9% | -12.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.